Carolyn Lam Singapore-born cardiologist
Lam, Carolyn S.P.
Lam, Carolyn Su Ping, 1974-
VIAF ID: 311464118 (Personal)
Permalink: http://viaf.org/viaf/311464118
Preferred Forms
- 100 0 _ ‡a Carolyn Lam ‡c Singapore-born cardiologist
- 100 1 _ ‡a Lam, Carolyn S. P.
- 100 1 _ ‡a Lam, Carolyn S. P.
- 100 1 _ ‡a Lam, Carolyn S.P.
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry | |
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management | |
Large-Scale Whole-Genome Sequencing of Three Diverse Asian Populations in Singapore | |
Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failure | |
Left ventricular function and exercise capacity | |
Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload | |
Light to Moderate Habitual Alcohol Consumption Is Associated with Subclinical Ventricular and Left Atrial Mechanical Dysfunction in an Asymptomatic Population: Dose-Response and Propensity Analysis | |
Longitudinal Community-Based Study of QT Interval and Mortality in Southeast Asians | |
Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles | |
Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings | |
Medical Podcasting and Circulation on the Run: Why, How, and What Now. | |
Membrane Proteomics of Impaired Energetics and Cytoskeletal Disorganization in Elderly Diet-Induced Diabetic Mice. | |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial | |
Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure | |
N-terminal pro-B-type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure | |
Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF | |
Natriuretic peptide receptor 3 (NPR3) is regulated by microRNA-100 | |
Natriuretic peptides, gender and cardiovascular risk: what is the link? | |
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure | |
Nitrates in combination with hydralazine in cardiorenal syndrome: a randomized controlled proof-of-concept study | |
Novel insights into heart failure with preserved ejection fraction | |
Obesity-Related Changes in Cardiac Structure and Function Among Asian Men and Women | |
Paradoxical Low-Gradient Aortic Stenosis: The HFpEF of Aortic Stenosis | |
Plasma extracellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease. | |
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration | |
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study | |
Potassium abnormalities in patients with heart failure from 11 Asian regions: insights from the ASIAN-HF registry | |
Prevalence and Clinical Significance of Diabetes in Asian Versus White Patients With Heart Failure | |
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure | |
Prognosis of Adults With Borderline Left Ventricular Ejection Fraction | |
Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy | |
Pulmonary pressures and death in heart failure: a community study | |
Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial | |
Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®. | |
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study | |
Racial Differences in Electrocardiographic Characteristics and Prognostic Significance in Whites Versus Asians | |
Random Plasma Glucose Levels and Cardiovascular Risk | |
Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE-ASIA-HF). | |
Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES). | |
Reply in response to 'Defining a "frequent admitter" phenotype among patients with repeat heart failure admissions' | |
Revisiting methods for assessing and comparing left ventricular diastolic stiffness: impact of relaxation, external forces, hypertrophy, and comparators | |
Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity | |
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study | |
Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score | |
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease | |
Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice | |
Sex and cardiovascular risk: are women advantaged or men disadvantaged? | |
Sex differences in heart failure |